Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Health Psychology Open
|
December 17, 2020
Risk and protective factors for intention of contraception use among women in Ghana
Manik Ahuja, Esther Frimpong, Joy Okoro, et al.
American Journal of Cancer Research
|
March 14, 2025
A novel gemcitabine analog as a potential anticancer agent: synthesis and <i>in-vitro</i> evaluation against pancreatic cancer
Joy Okoro, Raviteja Bulusu, Esther Frimpong, et al.
Psychological Reports
|
December 31, 2021
Feeling Not Wanted/Loved and Depression: Does Gender Matter?
Manik Ahuja, Joy Okoro, Esther Frimpong, et al.
American Journal of Cancer Research
|
March 14, 2025
Sociodemographic characteristics associated with pancreatic cancer incidence and mortality among Blacks in the United States: a SEER-based study
Esther Frimpong, Eugene Annor, Raviteja Bulusu, et al.
American Journal of Cancer Research
|
September 15, 2025
Enhanced anticancer activity of novel pyrimidine nucleoside analog in pancreatic cancer
Raviteja Bulusu, Joy Okoro, Esther Frimpong, et al.
International Journal of Pharmaceutics: X
|
April 24, 2026
Anti-EGFR liposomal drug delivery system loaded with AGY<sub>2</sub> potentiates the anti-cancer effect of AGY<sub>2</sub> against EGFR expressed pancreatic cancer
Raviteja Bulusu, Esther Frimpong, Joy Okoro, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 30, 2024
Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer
Esther Frimpong, Raviteja Bulusu, Joy Okoro, et al.
BMC Cancer
|
December 22, 2022
Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer
Nkafu Bechem Ndemazie, Andriana Inkoom, Dexter Ebesoh, et al.
BMC Cancer
|
May 13, 2023
Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer
Andriana Inkoom, Nkafu Bechem Ndemazie, Taylor Smith, et al.
Journal of the National Medical Association
|
February 21, 2023
Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans
Guettchina Telisnor, David L DeRemer, Esther Frimpong, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Health Psychology Open
|
December 17, 2020
Risk and protective factors for intention of contraception use among women in Ghana
Manik Ahuja, Esther Frimpong, Joy Okoro, et al.
American Journal of Cancer Research
|
March 14, 2025
A novel gemcitabine analog as a potential anticancer agent: synthesis and <i>in-vitro</i> evaluation against pancreatic cancer
Joy Okoro, Raviteja Bulusu, Esther Frimpong, et al.
Psychological Reports
|
December 31, 2021
Feeling Not Wanted/Loved and Depression: Does Gender Matter?
Manik Ahuja, Joy Okoro, Esther Frimpong, et al.
American Journal of Cancer Research
|
March 14, 2025
Sociodemographic characteristics associated with pancreatic cancer incidence and mortality among Blacks in the United States: a SEER-based study
Esther Frimpong, Eugene Annor, Raviteja Bulusu, et al.
American Journal of Cancer Research
|
September 15, 2025
Enhanced anticancer activity of novel pyrimidine nucleoside analog in pancreatic cancer
Raviteja Bulusu, Joy Okoro, Esther Frimpong, et al.
International Journal of Pharmaceutics: X
|
April 24, 2026
Anti-EGFR liposomal drug delivery system loaded with AGY<sub>2</sub> potentiates the anti-cancer effect of AGY<sub>2</sub> against EGFR expressed pancreatic cancer
Raviteja Bulusu, Esther Frimpong, Joy Okoro, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 30, 2024
Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer
Esther Frimpong, Raviteja Bulusu, Joy Okoro, et al.
BMC Cancer
|
December 22, 2022
Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer
Nkafu Bechem Ndemazie, Andriana Inkoom, Dexter Ebesoh, et al.
BMC Cancer
|
May 13, 2023
Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer
Andriana Inkoom, Nkafu Bechem Ndemazie, Taylor Smith, et al.
Journal of the National Medical Association
|
February 21, 2023
Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans
Guettchina Telisnor, David L DeRemer, Esther Frimpong, et al.
Page
of 2